C. Luo

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Zeqi Zheng, Jinlong Li, Lang Hong, 2022, Frontiers in Cardiovascular Medicine.

Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis

S. Dorman, M. Reichler, T. Sterling, 2018, The Journal of infectious diseases.

Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada

S. Dorman, M. Reichler, T. Sterling, 2020, BMC Infectious Diseases.

Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndro

Xia Li, Yulan Zhao, Zhenyu Yang, 2023, European Journal of Medical Research.

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Zhaohua Lu, Zheng Ji, C. Luo, 2022, Frontiers in Cardiovascular Medicine.